EEG Changes in Patients with Alzheimer’s Disease

被引：0

作者：

S. G. Burd ^{[1
]}

A. V. Lebedeva ^{[2
]}

Yu. V. Rubleva ^{[1
]}

N. V. Pantina ^{[2
]}

A. P. Efimenko ^{[1
]}

I. I. Kovaleva ^{[1
]}

机构：

[1] Federal Brain and Neurotechnologies Center, Russian Federal Medical Biological Agency, Moscow

[2] Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow

来源：

Neuroscience and Behavioral Physiology | 2024年 / 54卷 / 6期

关键词：

Alzheimer’s disease; coherence; dementia; EEG; spectral analysis;

D O I：

10.1007/s11055-024-01687-7

中图分类号：

学科分类号：

摘要：

The prevalence of cognitive impairment is steadily increasing throughout the world. The World Health Organization has reported that by 2030 there will be up to 82 million people with dementia, this increasing to 152 million by 2050. The most common cause is Alzheimer’s disease (AD). Given that the pathophysiological process in AD begins several years before the onset of clinical symptoms, identification of AD at an early stage would probably improve the clinical prognosis. This report presents data on EEG changes detected in patients with AD and also discusses the possibility of using electroencephalography as a screening method for examining patients with cognitive deficits. © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024.

引用

页码：866 / 869

页数：3

共 40 条

[1]

Hakim A.M., A proposed hypothesis on dementia: inflammation, small vessel disease, and hypoperfusion is the sequence that links all harmful lifestyles to cognitive impairment, Front. Aging Neurosci, 13, (2021)

[2]

Patterson C., World Alzheimer Report 2018, (2018)

[3]

Niu H., Alvarez-Alvarez I., Guillen-Grima F., Et al., Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: metaanálisis, Neurologia, 32, 8, pp. 523-532, (2017)

[4]

Bogolepova A.N., Vasenina E.E., Gomzyakova N.A., Et al., Clinical guidelines for cognitive disorders in elderly and older patients, Zh. Nevrol. Psikhiatr., 121, pp. 6-137, (2021)

[5]

Vasenina E.E., Levin O.S., Sonin A.G., Current trends in the epidemiology of dementia and management of patients with cognitive impairment, pp. 87-95, (2017)

[6]

Babiloni C., Lizio R., Marzano N., Et al., Brain neural synchronization and functional coupling in Alzheimer’s disease as revealed by resting state EEG rhythms, Int. J. Psychophysiol, 103, pp. 88-102, (2016)

[7]

Emelin A.Y., New criteria for the diagnosis of Alzheimer’s disease, Nevrol. Neiropsikh. Psikhosom., 3, No. 4, pp. 5-8, (2011)

[8]

Koberskaya N.N., Alzheimer’s disease: New diagnostic criteria and therapeutic aspects depending on the stage of the disease, Med. Sovet, 10, pp. 18-24, (2017)

[9]

Albert M.S., DeKosky S.T., Et al., The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 3, pp. 270-279, (2011)

[10]

Scheltens P., Leys D., Barkhof F., Et al., Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates, J Neurol. Neurosurg. Psychiatry, 55, 10, pp. 967-972, (1992)

← 1 2 3 4 →